Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Pediatr Dermatol ; 35(3): e155-e158, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29575091

RESUMO

We describe the difficulties of treating acne in a series of female-to-male transgender adolescents, including concerns about potential hepatotoxicity with concomitant use of testosterone with isotretinoin or tetracyclines. Acne is a foreseeable adverse effect of testosterone treatment in transgender adolescents, so monitoring for acne is advised. The treatment of acne in transgender adolescents is important given that severe acne and transgenderism are associated with higher rates of depression and suicide.


Assuntos
Acne Vulgar/tratamento farmacológico , Doxiciclina/uso terapêutico , Isotretinoína/uso terapêutico , Testosterona/efeitos adversos , Pessoas Transgênero , Acne Vulgar/etiologia , Adolescente , Antibacterianos/uso terapêutico , Fármacos Dermatológicos/uso terapêutico , Feminino , Humanos , Masculino
2.
An Pediatr (Engl Ed) ; 96(4): 349.e1-349.e11, 2022 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-35534418

RESUMO

Some people, including minors, have a gender identity that does not correspond to the sex assigned at birth. They are known as trans* people, which is an umbrella term that encompasses transgender, transsexual, and other identities not conforming to the assigned gender. Healthcare units for trans* minors require multidisciplinary working, undertaken by personnel expert in gender identity, enabling, when requested, interventions for the minor and their social-familial environment, in an individualized and flexible way during the gender affirmation path. This service model also includes hormonal treatments tailored as much as possible to the individual's needs, beyond the dichotomic goals of a traditional binary model. This guide addresses the general aspects of professional care of trans* minors and presents the current evidence-based protocol of hormonal treatments for trans* and non-binary adolescents. In addition, it details key aspects related to expected body changes and their possible side effects, as well as prior counselling about fertility preservation.


Assuntos
Disforia de Gênero , Guias de Prática Clínica como Assunto , Pessoas Transgênero , Transexualidade , Adolescente , Feminino , Disforia de Gênero/tratamento farmacológico , Identidade de Gênero , Humanos , Masculino , Menores de Idade , Transexualidade/terapia
3.
Front Nutr ; 8: 781229, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-35265650

RESUMO

Introduction: Hyponatremia often occurs during the practice of endurance sports. We evaluated the impact on hyponatremia of the hydration recommendations of the Third International Exercise-Associated Hyponatremia Consensus Development Conference 2015 (3IE-AHCD) during the 2017 Gran Trail de Peñalara marathon (GTP) and the Vitoria Gasteiz Ironman triathlon (VGI). Methods: Prospective study of GTP and VGI athletes participating in four information sessions in the months prior to the events, to explain that hydration should only be according to their level of thirst, per the recommendations of the 3IE-AHCD. Consenting event finishers were included in final analysis. Pre- and post-race anthropometric and biochemical parameters were compared. Results: Thirty-six GTP (33 male) and 94 VGI (88 male) finishers were evaluated. GTP race median fluid intake was 800 ml/h, with 900 ml/h in the VGI race. 83.3% GTPfin and 77.6% VGIfin remained eunatremic (blood sodium 135-145 mmol/L). Only 1/36 GTP and 1/94 VGI participant finished in hyponatremia, both with a sodium level of 134 mmol/L. Fourteen percent of GTP, and 21.2% of VGI participants finished in hypernatremia, with no increase in race completion times. No participating athlete required medical attention, except for musculoskeletal complaints. Pro-BNP and Copeptin levels rose significantly. Changes in copeptin levels did not correlate with changes in plasma osmolality, nor total body water content in impedance analysis. Conclusions: Recommending that athletes' fluid intake in endurance events be a function of their thirst almost entirely prevented development of hyponatremia, without induction of clinically significant hypernatremia, or a negative repercussion on race completion times.

4.
An Pediatr (Engl Ed) ; 93(1): 41-48, 2020 Jul.
Artigo em Espanhol | MEDLINE | ID: mdl-32144041

RESUMO

OBJECTIVES: To evaluate the psychosocial status of the patients who attend a paediatric endocrinology clinic due to gender incongruity (GI), and to establish the impact on this after one-year of cross hormonal therapy (CHT). MATERIAL AND METHODS: An analytical and prospective study conducted on adolescents between 14 and 18 years old with GI, and who attended the Endocrinology clinic during 2018-2019. The sample included 23 transgender cases (16 male and 7 female cases) and 30 cisgender controls. Study variables were collected at T0 (pre-treatment) and T1 (after one year of CHT) and included sociodemographic data, Utrecht test, SDQ-Cas test, family APGAR test, STAI scale-anxiety Grade, and BDI-II depression assessment test. RESULTS: A significant improvement (P<.05) was found between T0 and T1 in the transgender group in terms of emotional symptoms, behaviour problems, hyperactivity symptoms, pro-social conduct, as well as in the degree of anxiety and depression measured by the SDQ-Cas test, the STAI and the BDI-II scale. There were significant differences in these scales between the transgender group and the controls at T0, however, the scores equalised at T1. The families in this sample of transgender patients provided a very favourable environment according to the scores obtained on the family APGAR scale. CONCLUSIONS: The rates of anxiety, emotional and behaviour distress, depressive symptomatology, as well as the feeling of gender dysphoria of these transgender patients were similar to those of non-transsexual population of the same age after one year of CHT initiated at ages between 14-18 years old.


Assuntos
Ansiedade/etiologia , Depressão/etiologia , Disforia de Gênero/psicologia , Terapia de Reposição Hormonal , Procedimentos de Readequação Sexual , Pessoas Transgênero/psicologia , Adolescente , Ansiedade/diagnóstico , Estudos de Casos e Controles , Depressão/diagnóstico , Feminino , Disforia de Gênero/diagnóstico , Disforia de Gênero/tratamento farmacológico , Hormônio Liberador de Gonadotropina/uso terapêutico , Humanos , Masculino , Estudos Prospectivos , Escalas de Graduação Psiquiátrica , Testosterona/uso terapêutico , Resultado do Tratamento
5.
An Pediatr (Engl Ed) ; 92(3): 173.e1-173.e8, 2020 Mar.
Artigo em Espanhol | MEDLINE | ID: mdl-32061527

RESUMO

Physical activity (PA) and exercise improve the overall quality of life, as well as prevent the onset of diseases in healthy children and adolescents, and as an aid to treat prevalent chronic diseases in childhood. PA and exercise are like medicine, but sedentary lifestyle and inactivity cause disease. In this article, the existing scientific evidence in this field is reviewed and recommendations for professionals involved in child health are updated. A good knowledge of how to prescribe exercise and PA in paediatrics in different diseases is necessary. Interventions to avoid inactivity of children and adolescents must be supported by the appropriate increase in the level of PA, through integration and training programs, which achieve both an overall improvement of the neuromuscular physical condition and also physical, cognitive, and psychosocial performance. The Health Promotion Committee of Spanish Paediatric Association proposes strategies that help to obtain this objective, aiming to improve the health of our patients through the practice of exercise and the increase in PA.


Assuntos
Doença Crônica/terapia , Exercício Físico , Adolescente , Criança , Pré-Escolar , Humanos
6.
Rev. chil. endocrinol. diabetes ; 9(2): 56-57, 2016. tab
Artigo em Espanhol | LILACS | ID: biblio-831346

RESUMO

Partial forms of diabetes insipidus (DI) can be combined sometimes with alterations in the functionality of antidiuretic hormone (ADH) as a result of other co-morbidities. These entities are sometimes combined, it being necessary to assess this possibility further diagnostic protocols in particular cases. If clinical patient is within the spectrum of a DI of neurohypophyseal origin is described.


Assuntos
Humanos , Masculino , Criança , Diabetes Insípido/diagnóstico , Polidipsia/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA